ArticleBlood advances2023

CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany.

Peter Bader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.